10X Genomics Inc (TXG) — Capital Reinvestment Ratio
Latest as of September 2025:
0.02x
10X Genomics Inc (TXG) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow ($43.21 Million) in capital expenditures ($687.00K). See TXG cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
$43.21 Million
USD
Capital Expenditures
$687.00K
USD
Data as of
Sep 2025
Most recent filing
10X Genomics Inc Capital Reinvestment Ratio (2019–2024)
This chart tracks 10X Genomics Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for 10X Genomics Inc (2019–2024)
Year-by-year Capital Reinvestment Ratio for 10X Genomics Inc from 2019 to 2024. For live market cap and broader valuation context, see market cap of 10X Genomics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.86x | $6.66 Million | $12.39 Million | ▲ +50.6% |
| 2019 | 1.24x | $34.63 Million | $42.77 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow